MktsMarkets

Emergent BioSolutions Inc.
NYSE: EBSKey statistics
EBS News
Stories mentioning EBS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 156,100 | 148,700 | 231,100 | 140,900 | 222,200 | 194,700 | 293,800 | 254,700 |
| Cost of Goods Sold | 72,000 | 84,900 | 85,900 | 66,900 | 88,500 | 118,000 | 122,600 | 296,100 |
| Gross Profit | 84,100 | 63,800 | 145,200 | 74,000 | 133,700 | 101,300 | 161,200 | (48,000) |
| Operating Expenses | ||||||||
| Research & Development | 10,500 | 12,100 | 13,500 | 12,500 | 15,100 | 9,100 | 13,800 | 32,700 |
| Sales General & Admin | 46,600 | 51,100 | 38,900 | 43,700 | 52,400 | 60,800 | 76,600 | 85,900 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 10,500 | (27,900) | 76,500 | 1,600 | 49,900 | (9,500) | 64,500 | (203,500) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 13,900 | (8,100) | (3,700) | (3,700) | 69,700 | (3,900) | 21,900 | (2,700) |
| Pretax Income | 13,400 | (50,700) | 57,600 | (16,800) | 92,700 | (27,600) | 142,400 | (269,800) |
| Tax Provision | 6,600 | 3,900 | 6,400 | (4,800) | 24,700 | 3,700 | 27,600 | 13,300 |
| Net Income (Loss) | 6,800 | (54,600) | 51,200 | (12,000) | 68,000 | (31,300) | 114,800 | (283,100) |
| Earnings Per Share (Basic) | 0.13 | (1.02) | 0.96 | (0.22) | 1.25 | (0.59) | 2.16 | (5.38) |
| Earnings Per Share (Diluted) | 0.07 | (0.96) | 0.91 | (0.22) | 1.19 | (0.59) | 2.06 | (5.38) |
| Weighted Average Shares Outstanding (Basic) | 51,900 | 53,500 | 53,200 | 54,200 | 54,400 | 53,000 | 53,100 | 52,600 |
| Weighted Average Shares Outstanding (Diluted) | 56,500 | 56,700 | 56,500 | 54,200 | 57,300 | 53,000 | 55,600 | 52,600 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About EBS
Emergent BioSolutions Inc. (NYSE: EBS) is a stock listed on the New York Stock Exchange under the ticker symbol EBS. It last traded at $6.23 (Oct 23, 2026, 4:00 PM ET), unchanged on the day. That gives Emergent BioSolutions a market capitalisation of $319.4M.
Over the past 52 weeks EBS has traded between $4.36 and $14.06.
Revenue for the quarter ended Mar 31, 2026 was $156.1M; net income $6.8M. Revenue was down 29.7% from $222.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $156.1M | $6.8M | 4.4% |
| Dec 31, 2025 | $148.7M | -$54.6M | -36.7% |
| Sep 30, 2025 | $231.1M | $51.2M | 22.2% |
| Jun 30, 2025 | $140.9M | -$12.0M | -8.5% |
From Emergent BioSolutions’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…